As of 2026-04-03, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 19.5x | 16.3x |
| Forward P/E multiples | 18.4x - 28.0x | 20.8x |
| Fair Price | (226.40) - (239.22) | (228.12) |
| Upside | -4655.4% - -4913.3% | -4690.0% |
| Date | EV/EBITDA |